References
- Shah SN, Asghar S, Choudhry MA, et al. Formulation and evaluation of natural gum-based sustained release matrix tablets of flurbiprofen using response surface methodology. Drug Dev Ind Pharm 2009;35:1470–8
- Kim CK, Yoon YS. Preparation and evaluation of flurbiprofen dry elixir as a novel dosage form using a spray drying technique. Int J Pharm 1995;120:21–31
- Oh DH, Park YJ, Kang JH, et al. Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change. Drug Deliv 2011;18:46–53
- Baek HH, Kwon SY, Rho SJ, et al. Enhanced solubility and bioavailability of flurbiprofen by cycloamylose. Arch Pharm Res 2011;34:391–8
- Li DX, Han MJ, Balakrishnan P, et al. Enhanced oral bioavailability of flurbiprofen by combined use of micelle solution and inclusion compound. Arch Pharm Res 2010;33:95–101
- David SE, Timmins P, Conway BR. Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs. Drug Dev Ind Pharm 2012;38:93–103
- Park KM, Lee MK, Hwang KJ, Kim CK. Phospholipid-based microemulsions of flurbiprofen by the spontaneous emulsification process. Int J Pharm 1999;183:145–54
- Yang W, Peters JI, Williams 3rd RO. Inhaled nanoparticles – a current review. Int J Pharm 2008;356:239–47
- Kim JH, Jang SW, Han SD, et al. Development of a novel ophthalmic ciclosporin A-loaded nanosuspension using top-down media milling methods. Pharmazie 2011;66:491–5
- Shin BS, Kim CH, Jun YS, et al. Oral absorption and pharmacokinetics of rebamipide and rebamipide lysinate in rats. Drug Dev Ind Pharm 2004;30:869–76
- Oh DH, Balakrishnan P, Oh YK, et al. Effect of process parameters on nanoemulsion droplet size and distribution in SPG membrane emulsification. Int J Pharm 2011;404:191–7
- Society of Toxicology (SOT). Guiding principles in the use of animals in toxicology. 2008. Available from: www.toxicology.org/AI/FA/guidingprinciples.pdf [last accessed December 2008].
- Han F, Li S, Yin R, et al. Investigation of nanostructured lipid carriers for transdermal delivery of flurbiprofen. Drug Dev Ind Pharm 2008;34:453–8
- Joseph S, Bunjes H. Preparation of nanoemulsions and solid lipid nanoparticles by premix membrane emulsification. J Pharm Sci 2012;101:2479–89
- Benjakul R, Panyarachun B, Sarisuta N. Preparation of dry reconstituted liposomal powder by freeze-drying at room temperature. J Liposome Res 2011;21:28–37
- Balakrishnan P, Lee BJ, Oh DH, et al. Enhanced oral bioavailability of dexibuprofen by a novel solid SEDDS formulation. Eur J Pharm Biopharm 2009;72:539–45
- Li DX, Oh YK, Lim SJ, et al. Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray drying technique. Int J Pharm 2008;355:277–84
- Kim DW, Kang JH, Oh DH, et al. Development of novel flurbiprofen-loaded solid self-microemulsifying drug delivery system using gelatin as solid carrier. J Microencapsul 2012;29:323–30
- Joe JH, Lee WM, Park YJ, et al. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus. Int J Pharm 2010;395:161–6
- Lim HT, Balakrishnan P, Oh DH, et al. Development of novel sibutramine base-loaded solid dispersion with gelatin and HPMC: physicochemical characterization and pharmacokinetics in beagle dogs. Int J Pharm 2010;397:225–30
- Shanmugam S, Park JH, Chi SC, et al. Physicochemical stability, pharmacokinetic, and biodistribution evaluation of paclitaxel solid dispersion prepared using supercritical antisolvent process. Drug Dev Ind Pharm 2011;37:628–37
- Newa M, Bhandari KH, Li DX, et al. Preparation and evaluation of immediate release ibuprofen solid dispersions using polyethylene glycol 4000. Biol Pharm Bull 2008;31:939–45